Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide and Saxagliptin Effects on Postprandial Lipids in Prediabetes
NCT02104739Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Apr 2014
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide, saxagliptin in prediabetes, sponsored by UTHealth Houston. Started Apr 2014; status: completed.
02
Drugs
exenatidesaxagliptin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT02104739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104739.